The coronary heart disease of phlegm-stasis cementation syndrome in mini-swine based on platelet proteomics
10.16438/j.0513-4870.2022-1294
- VernacularTitle:基于血小板蛋白质组学探讨小型猪痰瘀互结证冠心病的发病机制
- Author:
Ying LI
;
Lei LI
;
Hong-xu MENG
;
Ao-ao WANG
;
Zi-yan WANG
;
Guo-yuan ZHANG
;
Yue SHI
;
Yan-lei MA
;
Li LIN
;
Jian-xun LIU
- Publication Type:Research Article
- Keywords:
phlegm-stasis cementation syndrome;
coronary heart disease;
platelet;
proteomics;
glycolysis/gluconeogenesis
- From:
Acta Pharmaceutica Sinica
2023;58(7):1904-1912
- CountryChina
- Language:Chinese
-
Abstract:
Based on the technology of platelet proteomics, the key regulatory proteins and pathogenesis of coronary heart disease with phlegm and blood stasis syndrome were explored and analyzed. Based on the previous laboratory research, the model of coronary heart disease in mini-swine with phlegm-stasis cementation syndrome was duplicated. The model was judged by the changes in blood lipid and myocardial tissue characteristics. Furthermore, the platelet proteins were studied by quantitative proteomics, and the differentially expressed proteins were screened. The critical regulatory proteins and biological pathways of coronary heart disease with phlegm-stasis cementation syndrome were analyzed by bioinformatics. After ten weeks of modeling, the levels of total cholesterol (TC), low-density lipoprotein cholesterol (LDL-C), very low density lipoprotein (VLDL-C), triglyceride (TG), creatine kinase (CK) and creatine kinase-MB (CK-MB) in the model group were significantly increased, reflecting the pathological changes such as increased blood lipid, abnormal coagulation function and myocardial ischemia in the model group. In addition, compared with the sham group, there were 26 up-regulated proteins and 8 down-regulated proteins in the platelets of the model group. Combined with bioinformatics analysis, it was found that differential proteins mainly involved in glycolysis/gluconeogenesis, pyruvate metabolism, lipid and atherosclerosis, Ras protein signal transduction. Among them, lactate dehydrogenase B (LDHB), alcohol dehydrogenase 5 (ADH5), neuroblastoma ratsarcoma viral oncogene homolog (NRAS) and Kirsten ratsarcoma viral oncogene homolog (KRAS) play a central role when interacting with other proteins and simultaneously participate in multiple action pathways. The results showed that LDHB, ADH5, NRAS, and KRAS may be the marker proteins in CHD with phlegm-stasis cementation syndrome by regulating glycolysis/gluconeogenesis, pyruvate metabolism, lipid and atherosclerosis, Ras protein signal transduction and other biological processes.
